RECOMMENDATION(S):
APPROVE and AUTHORIZE the Auditor-Controller or designee, to pay an amount not to exceed $51,405 to DiaSorin Inc. for reagents and controls for the DiaSorin Liaison XL Analyzer, for the Clinical Laboratory at the Contra Costa Regional Medical Center (CCRMC) during the period of March 22, 2023 through March 30, 2023.
FISCAL IMPACT:
Approval of this action will result in a one-time expenditure in an amount not to exceed $51,405 and will be funded entirely by Hospital Enterprise Fund I revenues.
BACKGROUND:
The CCRMC Clinical Laboratory uses the DiaSorin Liaison XL Analyzer for numerous specialty tests such as Measles, Mumps, Rubella, QuantiFERON TB testing, and the recent addition of VZV (chickenpox) testing performed routinely on patient samples within the Clinical Laboratory.
|